RecruitingNCT06367686

Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor

Detecting Systemic Carbon Dioxide Levels With a Novel Biosensor; The DISCO-study

Sponsor

The Hospital of Vestfold

Enrollment

11 participants

Start Date

Jan 30, 2025

Study Type

OBSERVATIONAL

Conditions

Hypercapnic respiratory failure Pulmonary Disease, Chronic Obstructive Neuromuscular Diseases Obesity Hypoventilation Syndrome (OHS)

Summary

The study is an open, prospective, single center clinical observational pilot investigation. The aim is to compare the carbon dioxide values measured by the IscAlert sensor, which is inserted in proximity to the nasal mucosa. The study wants to investigate if the nasal mucosa application and measurements are feasible, what kind of possible complications such a measurement can cause, and if the measurements can be a surrogate marker for systemic carbon dioxide values.

Eligibility

Min Age: 18 YearsMax Age: 110 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called IscAlert sensor for people with hypercapnic respiratory failure, neuromuscular diseases, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 110 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.